Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Including ovarian morphology in diagnosis increases PCOS prevalence estimates, highlighting the need for standardized criteria.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Lasers and intense pulsed light can safely and effectively remove hair by targeting hair follicles.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

PCOS requires personalized treatment to manage symptoms and improve fertility and quality of life.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Probiotics and synbiotics might help manage hirsutism by improving insulin resistance.

Microneedles improve delivery of plant-based compounds through the skin, aiding treatments for hair loss, cancer, and wounds.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

STK11 gene polymorphism does not predict metformin response in PCOS.

Melasma's causes include genetics, sun exposure, hormones, and oxidative stress, and understanding these can help create better treatments.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Further research is needed to develop effective cancer prevention strategies.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Microneedles in wearables can deliver drugs over time but face challenges in manufacturing and safety.

Sertraline, an antidepressant, may rarely cause hair loss.

Sertraline, an antidepressant, may cause hair loss in rare cases.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

m6A deregulation plays a key role in PCOS and could lead to new treatments.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Adult female acne requires personalized treatment and maintenance to prevent relapse.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Hirsutism can occur in women with PCOS even if their androgen levels are normal, making diagnosis challenging.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.